Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

SCCA2 a potential marker of disease activity, treatment efficacy in atopic dermatitis

31 Aug 2017

Serum levels of squamous cell carcinoma antigen 2 (SCCA2) are indicative of disease severity and clinical type of atopic dermatitis (AD), according to a recent study, suggesting that SCCA2 may be a novel and useful marker for evaluating disease activity and treatment efficacy in AD.

The study included 240 adult patients with AD and 25 healthy controls. Serum SCCA2 levels were measured using an enzyme-linked immunosorbent assay. SCCA2 was analysed in relation to clinical characteristics and laboratory parameters including thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), blood eosinophils, total IgE, and specific IgE (eg, Japanese cedar pollen, Dermatophagoides farina, Candida, malassezia, Staphylococcal enterotoxin B).

Other assessments included the expression of SCCA2 in AD eruption and the effect of treatment on serum SCCA2.

Serum SCCA2 levels were positively associated with disease severity, levels of TARC, LDH, eosinophil counts and IgE levels. Robust SCCA2 expression was identified in the supra basal keratinocytes in the epidermis of AD patients.

When SCCA2 was analysed by clinical types of AD, serum levels were significantly higher in patients with erythroderma type vs other types. In patients whose lesions were not widely distributed, such as those with limb type, SCCA2 levels were lower. No association was noted between the severity of prurigo type AD and serum levels of SCCA2.

Aside from reflecting the extent of lesional skin, SCCA2 levels were also likely to better indicate the extent of chronic inflammation.

Overall, SCCA2 levels decreased after treatment for AD.

Known as a tumour biomarker for various squamous cell tumours, SCCA comprises two nearly identical proteins, SCCA1 and SCCA2. Both proteins belong to the ovalbumin-serpin proteinase inhibitor family and have shown activity against different proteases. [Clinic Rev Allergy Immunol 2013;45:267–280]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.